Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914915903> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2914915903 endingPage "e29" @default.
- W2914915903 startingPage "e28" @default.
- W2914915903 abstract "Purpose: Cabozantinib is a multi-targeted tyrosine kinase inhibitor, approved for treatment in advanced renal cancer carcinoma (aRCC) patients who had prior anti-angiogenic agents. Cabozantinib was provided free-of-cost through a managed access programme (MAP) in Scotland from October 2016 until SMC approval in June 2017. We aim to evaluate outcomes with cabozantinib and identify potential cost savings from participation in the MAP." @default.
- W2914915903 created "2019-02-21" @default.
- W2914915903 creator A5009282743 @default.
- W2914915903 creator A5024970496 @default.
- W2914915903 creator A5048796030 @default.
- W2914915903 creator A5064906574 @default.
- W2914915903 creator A5070333770 @default.
- W2914915903 creator A5081388116 @default.
- W2914915903 date "2019-02-01" @default.
- W2914915903 modified "2023-10-18" @default.
- W2914915903 title "Real-world Experience of Cabozantinib in Patients with Metastatic Renal Cell Carcinoma and Cost Saving from Free-of-Cost Access Scheme" @default.
- W2914915903 doi "https://doi.org/10.1016/j.clon.2018.11.030" @default.
- W2914915903 hasPublicationYear "2019" @default.
- W2914915903 type Work @default.
- W2914915903 sameAs 2914915903 @default.
- W2914915903 citedByCount "0" @default.
- W2914915903 crossrefType "journal-article" @default.
- W2914915903 hasAuthorship W2914915903A5009282743 @default.
- W2914915903 hasAuthorship W2914915903A5024970496 @default.
- W2914915903 hasAuthorship W2914915903A5048796030 @default.
- W2914915903 hasAuthorship W2914915903A5064906574 @default.
- W2914915903 hasAuthorship W2914915903A5070333770 @default.
- W2914915903 hasAuthorship W2914915903A5081388116 @default.
- W2914915903 hasConcept C121608353 @default.
- W2914915903 hasConcept C126322002 @default.
- W2914915903 hasConcept C143998085 @default.
- W2914915903 hasConcept C2775832928 @default.
- W2914915903 hasConcept C2777472916 @default.
- W2914915903 hasConcept C2778820342 @default.
- W2914915903 hasConcept C2781064419 @default.
- W2914915903 hasConcept C2781068499 @default.
- W2914915903 hasConcept C71924100 @default.
- W2914915903 hasConceptScore W2914915903C121608353 @default.
- W2914915903 hasConceptScore W2914915903C126322002 @default.
- W2914915903 hasConceptScore W2914915903C143998085 @default.
- W2914915903 hasConceptScore W2914915903C2775832928 @default.
- W2914915903 hasConceptScore W2914915903C2777472916 @default.
- W2914915903 hasConceptScore W2914915903C2778820342 @default.
- W2914915903 hasConceptScore W2914915903C2781064419 @default.
- W2914915903 hasConceptScore W2914915903C2781068499 @default.
- W2914915903 hasConceptScore W2914915903C71924100 @default.
- W2914915903 hasIssue "2" @default.
- W2914915903 hasLocation W29149159031 @default.
- W2914915903 hasOpenAccess W2914915903 @default.
- W2914915903 hasPrimaryLocation W29149159031 @default.
- W2914915903 hasRelatedWork W2740343583 @default.
- W2914915903 hasRelatedWork W2792841998 @default.
- W2914915903 hasRelatedWork W2896683739 @default.
- W2914915903 hasRelatedWork W2943049136 @default.
- W2914915903 hasRelatedWork W3010596500 @default.
- W2914915903 hasRelatedWork W4229866436 @default.
- W2914915903 hasRelatedWork W4285598862 @default.
- W2914915903 hasRelatedWork W4313210082 @default.
- W2914915903 hasRelatedWork W4317480275 @default.
- W2914915903 hasRelatedWork W4362587156 @default.
- W2914915903 hasVolume "31" @default.
- W2914915903 isParatext "false" @default.
- W2914915903 isRetracted "false" @default.
- W2914915903 magId "2914915903" @default.
- W2914915903 workType "article" @default.